<?xml version='1.0' encoding='utf-8'?>
<document id="24894748"><sentence text="A metoprolol-terbinafine combination induced bradycardia."><entity charOffset="2-12" id="DDI-PubMed.24894748.s1.e0" text="metoprolol" /><entity charOffset="13-24" id="DDI-PubMed.24894748.s1.e1" text="terbinafine" /><pair ddi="false" e1="DDI-PubMed.24894748.s1.e0" e2="DDI-PubMed.24894748.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24894748.s1.e0" e2="DDI-PubMed.24894748.s1.e1" /></sentence><sentence text="To report a sinus bradycardia induced by metoprolol and terbinafine drug-drug interaction and its management"><entity charOffset="41-51" id="DDI-PubMed.24894748.s2.e0" text="metoprolol" /><entity charOffset="56-67" id="DDI-PubMed.24894748.s2.e1" text="terbinafine" /><pair ddi="false" e1="DDI-PubMed.24894748.s2.e0" e2="DDI-PubMed.24894748.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24894748.s2.e0" e2="DDI-PubMed.24894748.s2.e1" /></sentence><sentence text=" A 63 year-old Caucasian man on metoprolol 200 mg/day for stable coronary artery disease was prescribed a 90-day course of oral terbinafine 250 mg/day for onychomycosis"><entity charOffset="32-42" id="DDI-PubMed.24894748.s3.e0" text="metoprolol" /><entity charOffset="128-139" id="DDI-PubMed.24894748.s3.e1" text="terbinafine" /><pair ddi="false" e1="DDI-PubMed.24894748.s3.e0" e2="DDI-PubMed.24894748.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24894748.s3.e0" e2="DDI-PubMed.24894748.s3.e1" /></sentence><sentence text=" On the 49th day of terbinafine therapy, he was brought to the emergency room for a decrease of his global health status, confusion and falls"><entity charOffset="20-31" id="DDI-PubMed.24894748.s4.e0" text="terbinafine" /></sentence><sentence text=" The electrocardiogram revealed a 37 beats/min sinus bradycardia" /><sentence text=" A score of 7 on the Naranjo adverse drug reaction probability scale indicates a probable relationship between the patient's sinus bradycardia and the drug interaction between metoprolol and terbinafine"><entity charOffset="176-186" id="DDI-PubMed.24894748.s6.e0" text="metoprolol" /><entity charOffset="191-202" id="DDI-PubMed.24894748.s6.e1" text="terbinafine" /><pair ddi="false" e1="DDI-PubMed.24894748.s6.e0" e2="DDI-PubMed.24894748.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24894748.s6.e0" e2="DDI-PubMed.24894748.s6.e1" /></sentence><sentence text=" The heart rate ameliorated first with a decrease in the dose of metoprolol"><entity charOffset="65-75" id="DDI-PubMed.24894748.s7.e0" text="metoprolol" /></sentence><sentence text=" It was subsequently changed to bisoprolol and the heart rate remained normal"><entity charOffset="32-42" id="DDI-PubMed.24894748.s8.e0" text="bisoprolol" /></sentence><sentence text=" By inhibiting the cytochrome P450 2D6, terbinafine had decreased metoprolol's clearance, leading in metoprolol accumulation which has resulted in clinically significant sinus bradycardia"><entity charOffset="40-51" id="DDI-PubMed.24894748.s9.e0" text="terbinafine" /><entity charOffset="101-111" id="DDI-PubMed.24894748.s9.e1" text="metoprolol" /><pair ddi="false" e1="DDI-PubMed.24894748.s9.e0" e2="DDI-PubMed.24894748.s9.e0" /><pair ddi="false" e1="DDI-PubMed.24894748.s9.e0" e2="DDI-PubMed.24894748.s9.e1" /></sentence><sentence text="" /></document>